Omega-3 fatty acids are a potential therapy for patients with sickle cell disease

Ahmed Daak^{1

2}, Adrian Rabinowicz^{3

4}, Kebreab Ghebremeskel⁵

Affiliations

¹ Center of Molecular Biology and Biotechnology (CMBB), Florida Atlantic University, Jupiter, FL, USA. adaak@fau.edu.
² Sancilio Pharmaceuticals Company, Riviera Beach, FL, USA. adaak@fau.edu.
³ Center of Molecular Biology and Biotechnology (CMBB), Florida Atlantic University, Jupiter, FL, USA.
⁴ Sancilio Pharmaceuticals Company, Riviera Beach, FL, USA.
⁵ Lipidomics and Nutrition Research Centre, London Metropolitan University, London, UK.

Comment

Ahmed Daak et al. Nat Rev Dis Primers. 2018.

. 2018 Aug 9;4(1):15.

doi: 10.1038/s41572-018-0012-9.

Ahmed Daak^{1

2}, Adrian Rabinowicz^{3

4}, Kebreab Ghebremeskel⁵

¹ Center of Molecular Biology and Biotechnology (CMBB), Florida Atlantic University, Jupiter, FL, USA. adaak@fau.edu.
² Sancilio Pharmaceuticals Company, Riviera Beach, FL, USA. adaak@fau.edu.
³ Center of Molecular Biology and Biotechnology (CMBB), Florida Atlantic University, Jupiter, FL, USA.
⁴ Sancilio Pharmaceuticals Company, Riviera Beach, FL, USA.
⁵ Lipidomics and Nutrition Research Centre, London Metropolitan University, London, UK.

No abstract available

Comment on

Sickle cell disease.
Kato GJ, Piel FB, Reid CD, Gaston MH, Ohene-Frempong K, Krishnamurti L, Smith WR, Panepinto JA, Weatherall DJ, Costa FF, Vichinsky EP. Kato GJ, et al. Nat Rev Dis Primers. 2018 Mar 15;4:18010. doi: 10.1038/nrdp.2018.10. Nat Rev Dis Primers. 2018. PMID: 29542687 Review.